companydata.dkcompanydata.dk

EnteroTarget ApS: Financial statements 2024

CVR: 39315769

Source: annual report 2024, Danish Business Authority

01/01/202431/12/2024

EnteroTarget ApS (CVR 39315769) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -535,054 and a net result of DKK -257,942 compared with DKK 281,965 the year before. Equity in the 2024 report amounted to DKK 484,481. The solvency ratio was 13%.

Gross Profit
DKK -535,054
Profit/Loss
DKK -257,942
Equity
DKK 484,481
Total Assets
DKK 3,725,214

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--535 t.-258 t.484 t.-
2023-100 t.282 t.742 t.-
2022-36 t.-7 t.460 t.-
2021--338 t.-268 t.-17 t.-
2020-60 t.47 t.252 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

EnteroTarget ApS: The 2023 annual report is outMay 6, 2024

EnteroTarget ApS has published its annual report for 2023. Gross profit came to DKK 100,178, and the net result was DKK 281,965.

Jesper Thorvald Troelsen joins the board of EnteroTarget ApSApr 29, 2024

As of April 29, 2024, Jesper Thorvald Troelsen has joined the board of directors of EnteroTarget ApS.

Sebastien Olivier Marie Pratt joins the board of EnteroTarget ApSApr 29, 2024

As of April 29, 2024, Sebastien Olivier Marie Pratt has joined the board of directors of EnteroTarget ApS.

Aditi Singh Ulvskjold leaves the board of EnteroTarget ApSApr 29, 2024

As of April 29, 2024, Aditi Singh Ulvskjold has left the board of directors of EnteroTarget ApS.

Jesper Thorvald Troelsen leaves the board of EnteroTarget ApSApr 28, 2024

As of April 28, 2024, Jesper Thorvald Troelsen has left the board of directors of EnteroTarget ApS.

About EnteroTarget ApS

EnteroTarget ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jørgen Olsen. The board consists of Jesper Thorvald Troelsen (chair), Jørgen Olsen, Mohammad Taha Yassin and Sebastien Olivier Marie Pratt. The company's owners include Stig Henning Møller Nielsen, NEO Anderson Holding ApS and TroePaz Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -743,935 and a net result of DKK -451,011 compared with DKK -257,942 the year before. Equity in the 2025 report amounted to DKK 4,079,894.

Source: annual report 2025, Danish Business Authority

Other financial years